This session was held on February 17 with Dr. Valerie Rusch of the Memorial Sloan Kettering Cancer Center. During the call, Dr. Rusch was interviewed by Mary Hesdorffer, the Meso Foundation’s executive director and experienced nurse practitioner. She discussed her new clinical trial for mesothelioma patients, GL-ONC1.
Dr. Valerie Rusch of the Memorial Sloan-Kettering Cancer Center is a thoracic surgeon with over 25 years of experience. Her focus is treatment of patients with cancers of the lung, airways (trachea, bronchi), esophagus, mediastinum, chest wall, and pleura (malignant pleural mesothelioma).
